Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00455156 · ClinicalTrials.gov registry record · Phase 3
Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring
A Phase 3 study, sponsored by Premier Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,200
- Enrollment target
NCT00455156 is a Phase 3 study that has completed, run by Premier Research. The registered enrollment target is 1,200 participants.
The verdict
NCT00455156, a Phase 3 study, has completed, sponsored by Premier Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,200 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the one-year data on the contraceptive efficacy and safety of the 150/15 NES/EE CVR as the basis for regulatory approvals of this CVR as a new delivery system for contraception.
Interventions
- DRUG 150 mg of Nestorone and 15 mg of ethinyl estradiol (150/15 NES/EE CVR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2006-12 |
| Est. Completion | 2011-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00455156
The ClinicalTrials.gov registry entry for NCT00455156 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Premier Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 150 mg of Nestorone and 15 mg of ethinyl estradiol (150/15 NES/EE CVR) is the first listed.
NCT00455156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00455156 about?
NCT00455156 is a clinical study titled "Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring". The purpose of this study is to evaluate the one-year data on the contraceptive efficacy and safety of the 150/15 NES/EE CVR as the basis for regulatory approvals of this CVR as a new delivery system for contraception.
What is the current status of trial NCT00455156?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,200 participants. The study started on 2006-12. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00455156?
The interventions under investigation include: 150 mg of Nestorone and 15 mg of ethinyl estradiol (150/15 NES/EE CVR) (DRUG).
Who is sponsoring clinical trial NCT00455156?
This trial is sponsored by Premier Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.